Heterocyclic Compounds, 2-Ring
"Heterocyclic Compounds, 2-Ring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of heterocyclic compounds that include a two-ring fused structure. Both aromatic and non-aromatic ring structures are included in this category.
| Descriptor ID |
D006574
|
| MeSH Number(s) |
D03.633.100
|
| Concept/Terms |
Heterocyclic Compounds, 2-Ring- Heterocyclic Compounds, 2-Ring
- 2-Ring Heterocyclic Compounds
- Heterocyclic Compounds, 2 Ring
- Two Ring Heterocyclic Compounds
- Fused Heterocyclic Compounds, Two-Ring
- Fused Heterocyclic Compounds, Two Ring
|
Below are MeSH descriptors whose meaning is more general than "Heterocyclic Compounds, 2-Ring".
Below are MeSH descriptors whose meaning is more specific than "Heterocyclic Compounds, 2-Ring".
This graph shows the total number of publications written about "Heterocyclic Compounds, 2-Ring" by people in this website by year, and whether "Heterocyclic Compounds, 2-Ring" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 3 | 0 | 3 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Heterocyclic Compounds, 2-Ring" by people in Profiles.
-
SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells. J Virol. 2021 08 10; 95(17):e0079421.
-
ß-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. Cell. 2020 12 10; 183(6):1520-1535.e14.
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial. JACC Heart Fail. 2018 02; 6(2):96-104.
-
Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study. Eur J Heart Fail. 2017 06; 19(6):782-791.
-
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study. Eur Heart J. 2017 04 14; 38(15):1119-1127.